Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice (Q35889827)

10 August 2017

Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice (English)

1 reference

10 August 2017

Ke Guo

1

1 reference

10 August 2017

Jing Ping Tang

2

1 reference

10 August 2017

Li Jie

3

1 reference

10 August 2017

Abdul Qader O Al-Aidaroos

4

1 reference

10 August 2017

Cheng William Hong

5

1 reference

10 August 2017

Cheng Peow Bobby Tan

6

1 reference

10 August 2017

Jung Eun Park

7

1 reference

10 August 2017

Leyon Varghese

8

1 reference

10 August 2017

Zhiwei Feng

9

1 reference

10 August 2017

Jianbiao Zhou

10

1 reference

10 August 2017

Wee Joo Chng

11

1 reference

10 August 2017

Qi Zeng

12

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

10 August 2017

1 reference

10 August 2017

3

1 reference

10 August 2017

2

1 reference

10 August 2017

158-171

1 reference

Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Targeting intracellular oncoproteins with antibody therapy or vaccination

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PRL-3 phosphatase and cancer metastasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PRL PTPs: mediators and markers of cancer progression

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Systemic spread is an early step in breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Comparing antibody and small-molecule therapies for cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PRL phosphatases as potential molecular targets in cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PRL-3 phosphatase is implicated in ovarian cancer growth

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Breast cancer metastasis: markers and models

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

PRL-3 and PRL-1 promote cell migration, invasion, and metastasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Reappraisal of serum starvation, the restriction point, G0, and G1 phase arrest points

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Current perspectives on HER2 testing: a review of national testing guidelines

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

A phosphatase associated with metastasis of colorectal cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-subunit of geranylgeranyltransferase II

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Penetration of autoantibodies into living epithelial cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

Upping the ante on antibodies.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326646

In vivo effect of anti-asialo GM1 antibody on natural killer activity

24 September 2018

1 reference

12 December 2020

Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells

1 reference

12 December 2020

Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice

1 reference

12 December 2020

Monoclonal antibody successes in the clinic

1 reference

12 December 2020

Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors

1 reference

12 December 2020

release_fpyp33736vgg5nzmlof4ri4vdm

Identifiers

DOI

10.18632/ONCOTARGET.442

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fpyp33736vgg5nzmlof4ri4vdm

24 November 2022

mapped directly with Wikidata item

1 reference

10 August 2017

1 reference